My lab is using functional genomics, molecular biology, biochemistry, and advanced imaging in both the yeast model and cultured human cells to study fundamental mechanisms of genome maintenance and stability. Failure to maintain genome integrity leads to mutations that can promote tumour formation. Normal genome maintenance mechanisms can be overwhelmed by carcinogen exposure, or the presence of germline or somatic variants that induce genomic instability. Our work is aimed at determining the causes of genomic instability as an enabling characteristic of tumour formation, and exploring the potential of these early events to suggest novel therapeutic targets. Currently we are working on several projects, briefly outlined below.
Roles of RNA processing in genome maintenance
Functional genomic screening of the yeast model, Saccharomyces cerevisiae, and of mammalian cells has revealed that most steps in RNA metabolism (including transcription, processing, and decay) can cause genome instability when disrupted. In some cases it is clear that mutations in RNA processing factors lead to transcription-coupled DNA:RNA hybrids that form R-loops. R-loop structures expose damage-prone single-stranded DNA, and can also impede DNA replication fork progression, causing breaks. Importantly, not all genome destabilizing RNA processing mutants create R-loops, and we are also interested in defining these alternative mechanisms.
RNA processing mutations are now recognized to occur in various tumours. These include widely distributed and frequent mutations of the spliceosome (e.g. SF3B1 in hematopoietic malignancies), mutations in the RNA degrading exosome (e.g. DIS3), and mRNA processing genes (e.g. FIP1L1). The importance of these cancer-associated mutations for genome maintenance and the potential for R-loop formation to contribute to cancer cell phenotypes is also under investigation. Finally, some yeast RNA processing mutants exhibit synthetic lethality with cancer-associated genome maintenance genes, and therefore represent candidate therapeutic targets. We are exploring the conservation of such interactions and the potential for inhibiting aspects of RNA metabolism for therapeutic benefit.
DNA repair: mutation signatures and transcription-replication conflicts
Mutational processes leave a characteristic pattern of mutations on tumour genomes based on the underlying biology that is disrupted or the causative environmental agent. While elegant computational methods can extract such mutation ‘signatures’ from tumour genomes, the mechanisms are usually unknown. We have established a yeast model for linking specific genetic changes in conserved genome integrity pathways, and their interactions with genotoxic drugs, to patterns of accumulated mutations using whole genome sequencing. Yeast provides a clean and tractable genetic system whose genome can be sequenced in an efficient, cost-effective manner. These signatures have led to new insights to biochemical mechanisms of DNA repair (e.g. slippage and realignment in DNA translesion synthesis polymerases: bioRxiv 086512, doi: https://doi.org/10.1101/086512) and to an appreciation that defects in DNA repair can increase transcription-replication conflicts.
Our observation that some DNA repair defects increase transcription-replication conflicts, likely due to R-loops impairing DNA replication, connects to a growing body of literature which links genome maintenance factors (e.g. BRCA2, XPF/XPG, the Fanconi Anemia pathway and p53) to the suppression of R-loop-mediated genome instability. Our group is actively pursuing various DNA repair proteins that can suppress R-loop formation in yeast and human cells. We are developing tools to directly probe the molecular mechanisms of these effects and screen for conditions which enhance R-loop formation genetically or chemically.
The global cellular response to genotoxic stress
We have a long-standing interest in how cells respond to environmental stress dating back to Dr. Stirling’s earliest research on molecular chaperones (c. 2002-2008). Currently, this work is focused on the ways in which RNA and protein quality control machinery respond to genotoxic chemicals. These pathways may serve as chemoresistance mechanisms in the face of genotoxic cancer therapies. Using the yeast model, we have found that transcriptome changes following genotoxic stress directly regulate the constituents of protein aggregate structures. We believe that factors ejected from chromatin due to the transcriptional upheaval of a stress response are captured by protein quality control machinery in order to promote adaptation and recovery. The interplay between transcriptome dynamics, protein quality control, and RNA quality control (i.e. through P-bodies and Stress Granules) is an active area of interest in the lab.
Milbury KL, Paul B, Lari A, Fowler C, Montpetit B & Stirling PC. Exonuclease domain mutants of yeast DIS3 display genome instability. Nucleus 10: 21-32, 2019. View Abstract
Parameswaran S, Vizeacoumar FS, Kalyanasundaram Bhanumathy K, Qin F, Islam MF, Toosi BM, Cunningham CE, Mousseau DD, Uppalapati MC, Stirling PC, Wu Y, Bonham K, Freywald A, Li H & Vizeacoumar FJ. Molecular characterization of an MLL1 fusion and its role in chromosomal instability. Mol Oncol 13: 422-440, 2019. View Abstract.
Tam AS, Sihota TS, Milbury KL, Zhang A, Mathew V & Stirling PC. Selective defects in gene expression control genome instability in yeast splicing mutants. Mol Biol Cell 30: 191-200, 2019. View Abstract
Fournier LA, Kumar A & Stirling PC. Chromatin as a platform for modulating the replication stress response. Genes (Basel) 9: E622, 2018. View Abstract
Novoa CA, Ang JS & Stirling PC. The A-like Faker assay for measuring yeast chromosome III stability. Methods Mol Biol 1672: 1-9, 2018. View Abstract
Chang EY, Novoa CA, Aristizabal MJ, Coulombe Y, Segovia R, Chaturvedi R, Shen Y, Keong C, Tam AS, Jones SJM, Masson JY, Kobor MS & Stirling PC. RECQ-like helicases Sgs1 and BLM regulate R-loop associated genome instability. J Cell Biol 216: 3991-4005, 2017. View Abstract
Mathew V, Tam AS, Milbury KL, Hofmann AK, Hughes CS, Morin GB, Loewen CJR & Stirling PC. Selective aggregation of the splicing factor Hsh155 suppresses splicing upon genotoxic stress. J Cell Biol 216: 4027-4040, 2017. View Abstract
Segovia R, Mathew V, Tam AS & Stirling PC. Genome-wide bisulfite sensitivity profiling of yeast suggests bisulfite inhibits transcription. Mutat Res 821: 13-19, 2017. View Abstract
Seid-Karbasi P, Ye XC, Zhang AW, Gladish N, Cheng SY, Rothe K, Pilsworth JA, Kang MA, Doolittle N, Jiang X, Stirling PC & Wasserman WW. CuboCube: Student creation of a cancer genetics e-textbook using open-access software for social learning. PLoS Biol 15: e2001192, 2017. View Abstract
Segovia R, Shen Y, Lujan SA, Jones SJ & Stirling PC. Hypermutation signature reveals a slippage and realignment model of translesion synthesis by Rev3 polymerase in cisplatin-treated yeast. Proc Natl Acad Sci USA 114: 2663-2668, 2017. View Abstract
Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O'Neil NJ, Santos ND, Silvester J, Wei V, Garcia J, Kabeer F, Lai D, Soriano P, Banath J, Chiu DS, Yap D, Le DD, Ye FB, Zhang A, Thu K, Soong J, Lin SC, Tsai AH, Osako T, Algara T, Saunders DN, Wong J, Xian J, Bally MB, Brenton JD, Brown GW, Shah SP, Cescon D, Mak TW, Caldas C, Stirling PC, Hieter P, Balasubramanian S & Aparicio S. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumors. Nat Commun 8: 14432 2017. View Abstract
Chang EY & Stirling PC. Replication fork protection factors controlling R-loop bypass and suppression. Genes (Basel) 8: pii: E33. doi: 10.3390/genes8010033, 2017. View Abstract
Ang JS, Duffy S, Segovia R, Stirling PC & Hieter P. Dosage mutator genes in Saccharomyces cerevisiae: A novel mutator mode-of-action of the Mph1 DNA helicase. Genetics 204: 975-986, 2016. View Abstract
Measday V & Stirling PC. Navigating yeast genome maintenance with functional genomics. Brief Funct Genomics 15: 119-129, 2016. View Abstract
Leung AW, Hung SS, Backstrom I, Ricaurte D, Kwok B, Poon S, McKinney S, Segovia R, Rawji J, Qadir MA, Aparicio S, Stirling PC, Steidl C & Bally MB. Combined use of gene expression modeling and siRNA screening identifies genes and pathways which enhance the activity of Cisplatin when added at no effect levels to non-small cell lung cancer cells in vitro. PLoS One 11: e0150675, 2016. View Abstract
Kofoed M, Milbury KL, Chiang JH, Sinha S, Ben Aroya S, Giaever G, Nislow C, Hieter P & Stirling PC. An updated collection of sequence barcoded temperature-sensitive alleles of yeast essential genes. G3 (Bethesda) 5: 1879-1887, 2015. View Abstract
Leung AYW, Dragowska WH, Ricaurte D, Kwok B, Mathew V, Roosendaal J, Ahluwalia A, Warburton C, Laskin JJ, Stirling PC, Qadir MA & Bally MA. 3'-Phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents. Oncotarget 6: 17161-17177, 2015. View Abstract
Segovia R, Tam AS & Stirling PC. Dissecting genetic and environmental mutation signatures with model organisims. Trends Genet 31: 465-474, 2015. View Abstract
Chan YA, Hieter P & Stirling PC. Mechanisms of genome instability induced by RNA processing defects. Trends Genet 30: 245-253, 2014. View Abstract
Stirling PC, Shen Y, Corbett R, Jones SJ & Hieter P. Genome destabilizing mutator alleles drive specific mutational trajectories in Saccharomyces cerevisiae. Genetics 196: 403-412, 2014. View Abstract
Chan YA, Aristizabal MJ, Lu YT, Luo Z, Hamza A, Kobor MS, Stirling PC & Hieter P. Genome-wide profiling of yeast DNA:RNA hybrid prone sites with DRIP-chip. PLoS Genet 10: e1004288 2014. View Abstract
Sorgjerd KM, Zako T, Sakono M, Stirling PC, Leroux MR, Saito T, Nilsson P, Sekimoto M, Saido TC and Maeda M. Human prefoldin inhibits Amyloid β (Aβ) fibrillation and contributes to formation of non-toxic Aβ aggregates. Biochemistry. 52, 3532-3542, 2013. View Abstract
van Pel DM*, Stirling PC*, Minaker SW, Sipahimalani P and Hieter P. Saccharomyces cerevisiae genetics predicts candidate therapeutic genetic interactions at the mammalian replication fork. G3 (Bethesda) 3, 273-282, 2013 *Authors contributed equally. View Abstract
Minaker SW, Filiatrault MC, Ben-Aroya S, Hieter P and Stirling PC. Biogenesis of RNA polymerases II and III requires the conserved GPN small GTPases in S. cerevisiae. Genetics 193, 853-864, 2013. View Abstract
Stirling PC*, Chan YA*, Minaker SW*, Aristizabal MJ, Barrett I, Sipahimalani P, Kobor, MS and Hieter P. R-loop mediated genome instability in mRNA cleavage and polyadenylation mutants. Genes Dev. 26, 163-175, 2012 *Authors contributed equally. View Abstract
Stirling PC, Crisp MJ, Basrai MA, Tucker CM, Dunham MJ, Spencer FA and Hieter P. Mutability and mutational spectrum of chromosome transmission fidelity (Ctf) genes. Chromosoma 121, 263-275, 2012. View Abstract
Stirling PC, Bloom MS, Solanki-Patil T, Smith S, Sipahimalani P, Li Z, Kofoed M, Ben-Aroya S, Myung K and Hieter P. The complete spectrum of yeast chromosome instability genes identifies candidate CIN cancer genes and functional roles for ASTRA complex components. PLoS Genet. 7, e1002057, 2011. *Faculty of 1000 rated. View Abstract
Lundin VF, Leroux MR* and Stirling PC*. Quality control of cytoskeletal proteins and human disease. Trends Biochem. Sci. Review. 35, 288-297, 2010. *Corresponding authors. View Abstract
Carroll SY*, Stirling PC*, Stimpson HE, Giesselman E, Schmitt MJ and Drubin DG. A yeast killer toxin screen provides insights into A/B toxin entry, trafficking and killing mechanisms. Dev. Cell 17, 552-560, 2009. *Authors contributed equally. *Faculty of 1000 rated. View Abstract
Dekker C*, Stirling PC*, Filmore H, McCormack EA, Pappenberger G, Paul A, Brost RL, Costanzo M, Boone C, Leroux MR and Willison KR. The interaction network of the chaperonin CCT. EMBO J. 27, 1837-1839, 2008.*Authors contributed equally. *Faculty of 1000 rated. View Abstract
Stirling PC, Srayko M, Takhar KS, Pozniakovsky A, Hyman AA and Leroux MR. Functional interaction between phosducin-like protein 2 and cytosolic chaperonin is essential for cytoskeletal protein function and cell cycle progression. Mol. Biol. Cell 18, 2336-2345, 2007. View Abstract
Martín-Benito J, Gómez-Reino J, Stirling PC, Lundin VF, Gómez-Puertas P, Boskovic J, Chacón P, Fernández JJ, Berenguer J, Leroux MR and Valpuesta JM. Divergent substrate-binding mechanisms reveal an evolutionary specialization of eukaryotic prefoldin compared to its archaeal counterpart. Structure 15, 101-110, 2007. View Abstract
Stirling PC, Bakhoum SF, Feigl AB and Leroux MR. Convergent evolution of clamp-like binding sites in diverse chaperones. Nat. Struct. Mol. Biol. 13, 865-870. 2006. Review. View Abstract
Stirling PC, Cuellar J, Alfaro GA, El Khadali F, Beh CT, Valpuesta JM, Melki R and Leroux MR. PhLP3 modulates CCT-mediated actin and tubulin folding via ternary complexes with substrates. J. Biol. Chem. 281, 7012-7021, 2006. View Abstract
Lundin VF*, Stirling PC*, Gomez-Reino J, Mwenifumbo JC, Obst JM, Valpuesta JM and Leroux MR. Molecular clamp mechanism of substrate binding by hydrophobic coiled coil residues in the archaeal chaperone prefoldin. Proc. Natl. Acad. Sci. USA 101, 4367-4372, 2004. *Authors contributed equally. *Faculty of 1000 rated. View Abstract
Stirling PC*, Lundin VF* and Leroux MR. Getting a grip on non-native proteins. EMBO Reports 4, 565-570, 2003. *Authors contributed equally. Review. View Abstract
Karissa Milbury, PhD Graduate Student, 2014-2018.
Didem Dikbas, Research Assistant, 2017-2018.
Kate Y. Jiang, Co-op Student, 2018.
Stephanie Ryall, Co-op Student, 2018.
Dr. Elyse Hope, PostDoctoral Fellow, 2017-2018.
Michael Yuen, MSc Graduate Student, 2015-2017.
Danni (Yidan) Zhu, Co-op Student, 2017.
Tianna Sihota, UBC Co-op Student, 2017.
Romulo Segovia, MSc Graduate Student, 2014-2017.
Carolina Arias Novoa, MSc Graduate Student, 2014-2017.
Liane Gagnier, Cancer Research Technologist, 2014 -2017.
Claire Fowler, UBC Co-op Student, 2016.
Anni Zhang, UBC Co-op Student, 2015.
Christelle Keong, Summer student 2015, Part-time researcher, 2016.
Gunjan Kumar, Research Student 2014.